Form D · Other
DiCE Molecules Corp
Menlo Park, CA · CIK 0001595038
Offering snapshot reported Feb 13, 2014 · SEC filing
- Reported sold
- $2.9M Offering amount: $3.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 13, 2014 | Initial | $2,899,925 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-211856
Source: Form D, filed Feb 13, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bedbrook | Director, Executive |
| Pehr Harbury | Director |
| Kevin Judice | Director, Executive |
| Phil Patten | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1455 Adams Drive, Suite 1610
Menlo Park, CA, 94025
Menlo Park, CA, 94025